Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/26/2024 | $400.00 | Overweight | Piper Sandler |
5/30/2024 | $388.00 | Outperform | Robert W. Baird |
3/6/2024 | $393.00 | Overweight | Barclays |
2/5/2024 | $334.00 → $372.00 | Neutral → Overweight | Cantor Fitzgerald |
2/5/2024 | $327.00 → $354.00 | Sector Perform → Outperform | RBC Capital Mkts |
2/1/2024 | $355.00 → $370.00 | Hold → Buy | Deutsche Bank |
1/4/2024 | $330.00 → $372.00 | Mkt Perform → Outperform | Bernstein |
12/11/2023 | $335.00 → $341.00 | Hold → Buy | Jefferies |
Reaffirming Previously Provided Outlook for Full-Year 2024, and adjusted EPS growth of at least 10% in 2025Confirming it is not Pursuing a Combination with Humana Inc.Confirming Continuing to Use Capital to Drive Shareholder Value, including Share Repurchase and DividendsBLOOMFIELD, Conn., Nov. 11, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group expects to reaffirm projected full year 2024 consolidated adjusted income from operations of at least $28.40 per share and adjusted EPS growth of at least 10% in 2025. Additionally, in light
Infirmary's hospitals, facilities and doctors on Alabama's Gulf Coast are now in-network for Cigna Healthcare MA customers MOBILE, Ala., Nov. 1, 2024 /PRNewswire/ -- Cigna Healthcare and Mobile-based Infirmary Health have reached an agreement that allows Cigna Healthcare's Medicare Advantage (MA) customers to have in-network access to Infirmary Health's hospitals, facilities and doctors. The agreement includes value-based aspects that are focused on improving customer health, lowering costs and achieving high-quality ratings. Infirmary Health is the largest nonprofit, non-gove
Total revenues for the third quarter 2024 increased 30% to $63.7 billionShareholders' net income for the third quarter 2024 was $0.7 billion, or $2.63 per shareAdjusted income from operations1 for the third quarter 2024 was $2.1 billion, or $7.51 per shareReaffirms 2024 outlook2 for adjusted income from operations1,2 of at least $28.40 per shareBLOOMFIELD, Conn., Oct. 31, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong third quarter 2024 results demonstrating focused execution across Evernorth Health Services and Cigna Healthcare. "Ou
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
Piper Sandler initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $400.00
Robert W. Baird initiated coverage of The Cigna Group with a rating of Outperform and set a new price target of $388.00
Barclays initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $393.00
SC 13G - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
10-Q - Cigna Group (0001739940) (Filer)
8-K - Cigna Group (0001739940) (Filer)
8-K - Cigna Group (0001739940) (Filer)
Total revenues for the third quarter 2024 increased 30% to $63.7 billionShareholders' net income for the third quarter 2024 was $0.7 billion, or $2.63 per shareAdjusted income from operations1 for the third quarter 2024 was $2.1 billion, or $7.51 per shareReaffirms 2024 outlook2 for adjusted income from operations1,2 of at least $28.40 per shareBLOOMFIELD, Conn., Oct. 31, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong third quarter 2024 results demonstrating focused execution across Evernorth Health Services and Cigna Healthcare. "Ou
BLOOMFIELD, Conn., Oct. 23, 2024 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.40 per share of its common stock, payable on December 19, 2024 to shareholders of record as of the close of business on December 4, 2024. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and serv
BLOOMFIELD, Conn., Oct. 3, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its third quarter 2024 financial results on Thursday, October 31, 2024, and will host a conference call the same day. Third quarter 2024 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call (888) 566-1889 (Domestic) (773) 799-3989 (International) Passcode: 103
As part of the company's initiative, thousands of employees logged 280,000 minutes of exercise over nine days Cigna leaders biked to Hartford, Conn.'s Dunkin' Park to host Boys & Girls Clubs members for a Yard Goats baseball game, with surprise appearances by UConn basketball coach and playersBLOOMFIELD, Conn., Sept. 9, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI) put out a challenge to its workforce this summer, inviting colleagues to join its first-ever Community Vitality Project, a nine-day challenge combining fun, fitness and fundraising. By logging more than 280,000 minutes of fitness activities and awarding their minutes spent moving, The Cigna Group employees helped determine how to
Brian Evanko to continue as Chief Financial Officer, will serve as new President and CEO of Cigna HealthcareAnn Dennison to join The Cigna Group as Deputy Chief Financial OfficerMike Triplett to retire by end of 2024 and Bryan Holgerson promoted to President of U.S. Commercial for Cigna HealthcareEric Palmer to assume expanded role leading enterprise strategy and corporate development, will continue as President and CEO of Evernorth Health ServicesBLOOMFIELD, Conn., Jan. 17, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to continue accelerating growth across Evernorth Health Services and Cigna Healthcare.
BLOOMFIELD, Conn., May 1, 2023 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023. CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023." alt="The Cigna Group (NYSE:CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023."> Since 2019, Dr. Philip Oz
Cigna Group (NYSE:CI) has outperformed the market over the past 20 years by 6.54% on an annualized basis producing an average annual return of 14.94%. Currently, Cigna Group has a market capitalization of $95.40 billion. Buying $100 In CI: If an investor had bought $100 of CI stock 20 years ago, it would be worth $1,660.76 today based on a price of $335.84 for CI at the time of writing. Cigna Group's Performance Over Last 20 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine and re
Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by attrition in Medicaid membership, partially offset by higher premium yields reflecting the medical cost trend. In the second quarter, UnitedHealth Group Inc (NYSE:UNH) and Elevance Health reported increasing pressure on Medicaid, creating uncertainty about when Medicaid margins will bottom out and when a potential recovery might occur. Centene Inc. (NYSE:CNC), Cigna Corp (NYSE:CI), and Molina Healthcare Inc. (NYSE:MOH) are trading at a 3x lower valuation than Elevance Health. While Elevan
Healthcare investors are expecting Republican presidential nominee Donald Trump to ease regulations on Medicare Advantage if the former president wins and returns to the White House. Under the Biden administration, the Centers for Medicare & Medicaid Services has hardened its stance on the program after it faced criticism for insurers overbilling the government and denying care to seniors too many times, the Wall Street Journal reported. Republicans tend to favor privatizing government services and have been friendlier to Medicare Advantage plans, a trend that investors are betting could continue under a second Trump administration. Also Read: UnitedHealth Analysts Boost Their Fore